Tempus

Tempus uses artificial intelligence to advance precision medicine, particularly in cancer treatment. The platform analyzes clinical and molecular data to help physicians make more informed treatment decisions. It combines genomic sequencing with clinical data to provide personalized insights for patient care.

Tempus was founded by Eric Lefkofsky and has built one of the world's largest libraries of clinical and molecular data, partnering with healthcare institutions to improve cancer outcomes through AI-driven analysis.

Not Available

Pros & Cons